<i>Clostridium ramosum</i>, an IgA Protease‐Producing Species and Its Ecology in the Human Intestinal Tract
S. Senda(Shiga University of Medical Science), Kunihiko Kobayashi(Saitama International Medical Center), Tadao Bamba, Keiko Hodohara, Yoshihide Fujiyama(Shiga University of Medical Science), Shiro Hosoda, Tsutomu Ushijima(Shiga University of Medical Science)
Cited by 53
Related Papers
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
|New England Journal of Medicine|2010|5.6k
Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC
|New England Journal of Medicine|2023|695
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial
|The Lancet Oncology|2019|642
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
|Annals of Oncology|2012|555
Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice
|Clinical Immunology|2003|491